Business · 02/12/2019Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 21 ANDAs from Multiple Applicants
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 21 abbreviated new drug applications (ANDAs) from various pharmaceutical companies, following written notifications that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →